AN2 Therapeutics Inc (ANTX)
1.34
+0.11
(+8.94%)
USD |
NASDAQ |
Nov 22, 16:00
1.34
0.00 (0.00%)
After-Hours: 20:00
AN2 Therapeutics Shares Outstanding: 29.88M for Nov. 6, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
November 06, 2024 | 29.88M |
September 30, 2024 | 29.87M |
August 05, 2024 | 29.84M |
June 30, 2024 | 29.83M |
May 06, 2024 | 29.83M |
April 23, 2024 | 29.83M |
March 31, 2024 | 29.82M |
March 22, 2024 | 29.77M |
March 15, 2024 | 29.77M |
December 31, 2023 | 29.74M |
November 02, 2023 | 29.74M |
September 30, 2023 | 29.74M |
August 18, 2023 | 29.71M |
August 04, 2023 | 21.93M |
June 30, 2023 | 21.93M |
Date | Value |
---|---|
May 04, 2023 | 19.43M |
April 19, 2023 | 19.43M |
March 31, 2023 | 19.43M |
March 22, 2023 | 19.40M |
March 15, 2023 | 19.40M |
December 31, 2022 | 19.40M |
November 02, 2022 | 19.40M |
September 30, 2022 | 19.40M |
August 08, 2022 | 19.40M |
June 30, 2022 | 19.40M |
May 06, 2022 | 19.40M |
March 31, 2022 | 18.71M |
March 25, 2022 | 18.74M |
March 21, 2022 | 18.14M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
18.14M
Minimum
Mar 21 2022
29.88M
Maximum
Nov 06 2024
24.15M
Average
21.93M
Median
Jun 30 2023
Shares Outstanding Benchmarks
Biomarin Pharmaceutical Inc | 190.58M |
Arbutus Biopharma Corp | 189.49M |
GlycoMimetics Inc | 64.48M |
FibroGen Inc | 100.77M |
Cidara Therapeutics Inc | 7.047M |